PLX R&D Expenses
Protalix Biotherapeutics Inc · R&D Expenses
PLX R&D Expenses
Latest reported$19.88Mperiod ending
PLX R&D Expenses ($0.00 → $19.88M)
Annual R&D Expenses
High-resolution chart · PNG
PLX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 19,054,000 | |
| 12,970,000 | |
| 17,093,000 | |
| 29,349,000 | |
| 29,734,000 | |
| 38,167,000 | |
| 44,616,000 | |
| 33,330,000 | |
| 28,834,000 | |
| 30,412,000 | |
| 20,025,000 | |
| 27,352,000 | |
| 29,225,000 | |
| 28,689,000 | |
| 31,043,000 | |
| 29,951,000 | |
| 21,638,000 | |
| 17,401,000 | |
| 12,861,000 | |
| 5,246,000 | |
| 3,524,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |